Details of the Drug Combinations

General Information of This Drug (ID: DMU6FOG)

Drug Name

Clorsulon DMU6FOG

Synonyms

CLORSULON; 60200-06-8; Curatrem; Clorsulonum [Latin]; Clorsulone [French]; Clorsulon [Spanish]; UNII-EG1ZDO6LRD; EG1ZDO6LRD; EINECS 262-100-2; MK 401; MK-401; BRN 2821757; 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide; 4-Amino-6-(trichlorovinyl)-m-benzenedisulfonamide; L 631529; L-631,529; 4-Amino-6-(trichlorovinyl)-1,3-benzenedisulfonamide; 4-Amino-6-(trichloroethenyl)-1,3-benzenedisulfonamide; 1,3-Benzenedisulfonamide, 4-amino-6-(trichloroethenyl)-; NCGC00016893-01; NCGC00182084-01

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Clorsulon + Panobinostat	DCG3WKW	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
------------------------------------------------------------------------------------

References

1	Modes of action of anthelmintic drugs. Vet J. 1997 Jul;154(1):11-34.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.